Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB vs VALPROATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

USTEKINUMAB vs VALPROATE: Safety Overview

Metric USTEKINUMAB VALPROATE
Total FAERS Reports 85,332 15,880
Deaths Reported 4,519 1,000
Death Rate 5.3% 6.3%
Hospitalizations 17,127 6,625
Average Patient Age 48.1 yrs 40.9 yrs
% Female Patients 60.3% 48.0%
FDA Approval Date N/A Dec 22, 2021
Manufacturer SANDOZ INC Fresenius Kabi USA, LLC
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Discontinued